Oncogenic CALR mutant C-terminus mediates dual binding to the thrombopoietin receptor triggering complex dimerization and activation by Papadopoulos, N, Nédélec, A, Derenne, A, Şulea, TA, Pecquet, C, Chachoua, I, Vertenoeil, G, Tilmant, T, Petrescu, A-J, Mazzucchelli, G, Iorga, BI, Vertommen, D, Constantinescu, SN

External validation of serum biomarkers predicting short-term and mid/long-term relapse in patients with Crohn’s disease stopping infliximab by Pierre, N, Huynh-Thu, VA, Baiwir, D, Mazzucchelli, G, Fléron, M, Trzpiot, L, Eppe, G, De Pauw, E, Laharie, D, Satsangi, J, Bossuyt, P, Vuitton, L, Vieujean, S, Colombel, J, Meuwis, M, Louis, E, GETAID and the SPARE-Biocycle research group